Inactive Instrument
Zalicus Inc Stock Nasdaq
Stocks
US98887C1053
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 746K 664K 616K 558K 1.05M 70.69M 1.07M 7.39M 2.9M 37M 2.8M 2.74M 118M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -14.18M -13.15M -11.91M -22.39M -1.51B -22.76M -158M -61.97M -790M -59.77M -58.54M -2.52B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.79% | -6.46% | +52.86% | +71.34% | 65.83B | |
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | |
| +6.91% | +6.41% | +9.61% | +73.07% | 51.2B | |
| +0.62% | +2.62% | +26.15% | +45.10% | 43.76B | |
| +3.95% | +9.82% | +20.33% | +132.04% | 42.09B | |
| +7.94% | +4.27% | +263.80% | +602.50% | 39.04B | |
| -0.40% | +9.42% | +18.44% | +59.06% | 34B | |
| +3.84% | -4.94% | +42.35% | +8.92% | 25.2B | |
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | |
| Average | +3.07% | +0.51% | +53.06% | +122.87% | 41.76B | |
| Weighted average by Cap. | +3.02% | +0.62% | +51.48% | +124.72% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.02 0.2 0.02 0.01 0.63 | 0.7 0.62 0.58 0.52 0.98 66.41 1 6.94 2.73 34.75 2.63 2.57 110.86 |
| Net income | -41.84M -37.25M -34.52M -31.28M -58.79M -3.96B -59.77M -414M -163M -2.07B -157M -154M -6.62B | -52.19M -46.45M -43.05M -39.01M -73.32M -4.94B -74.55M -517M -203M -2.59B -196M -192M -8.25B |
| Net Debt | -14.18M -12.62M -11.7M -10.6M -19.92M -1.34B -20.25M -140M -55.14M -703M -53.19M -52.09M -2.24B | -16.68M -14.85M -13.76M -12.47M -23.44M -1.58B -23.83M -165M -64.87M -827M -62.57M -61.28M -2.64B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
